Log in

PEB Pacific Edge Limited NZX · New Zealand

Pacific Edge (PEB) news

Pacific Edge Limited is a public biotech or pharmaceutical company listed on NZX under the ticker PEB, recorded under New Zealand. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Pacific Edge news

We have not published a story on Pacific Edge yet. When there is news, it will appear here.

Questions about Pacific Edge

What is the ticker symbol of Pacific Edge?

Pacific Edge Limited trades under the ticker PEB on NZX.

Where is Pacific Edge listed?

Pacific Edge Limited is listed on NZX. Our directory also records these other listings: ASX:PEB.

Which country or territory is Pacific Edge listed under?

Our directory records Pacific Edge Limited under New Zealand.

What does Pacific Edge do?

Our directory classifies Pacific Edge Limited as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Pacific Edge?

The ISIN recorded for Pacific Edge Limited is NZPEBE0002S1.

Does aibio.space cover Pacific Edge?

aibio.space lists Pacific Edge Limited among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Pacific Edge?

Companies in our directory listed in the same country and business area as Pacific Edge: Promisia Healthcare, BLIS Technologies, AFT Pharmaceuticals, Zoono Group.

Investor discussion: Pacific Edge

Members talk about Pacific Edge (PEB). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NZX:PEB on TradingView.

Listing details

Pacific Edge Limited is a public biotech or pharmaceutical company listed on NZX under the ticker PEB, recorded under New Zealand. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Pacific Edge Limited
Ticker
PEB
Listing
NZX
Country or territory
New Zealand
Business scope
Biotechnology
ISIN
NZPEBE0002S1
Other listed symbols
ASX:PEB
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.